ArticleJournal of clinical practice and research2025
Effect of Glomerular Filtration Rate on Uric Acid Metabolism in a Retrospective Cohort of Type-2 Diabetes Mellitus Patients on SGLT-2 Inhibitor Therapy.
Article in Journal of clinical practice and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the effects of different glomerular filtration rates (GFRs) on serum uric acid (SUA) levels in patients with type 2 diabetes mellitus receiving sodium-glucose transporter 2 (SGLT-2) inhibitor therapy. Materials and Methods: A total of 3,004 patients with type 2 diabetes mellitus treated with SGLT-2 inhibitors between January 2017 and September 2022 were analyzed. Patients who did not attend follow-up visits, had missing data, discontinued SGLT-2 inhibitors, were taking medications that affect SUA levels, or were being treated for gout were excluded. The final study group consisted of 410 patients. Biochemical parameters were retrospectively compared before treatment and at the 3 Results: The study showed that glycated hemoglobin, fasting plasma glucose, creatinine, low-density lipoprotein, triglycerides, and SUA levels decreased with SGLT-2 inhibitor treatment, while high-density lipoprotein and urine glucose levels increased. The efficacy of SGLT-2 inhibitors in reducing SUA levels was found to correlate closely with changes in GFR, with a notable reduction observed at GFR levels below 60 mL/min/1.73 m Conclusion: SGLT-2 inhibitors not only regulate blood glucose levels and lipid profiles but also have a significant impact on uric acid levels. However, this study found that this effect is considerably diminished in patients with extremely low GFR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.